Ridgepost Capital, Inc. quarterly report, Q1 FY2024

Filing summary

Entity and period: The supplied filing is P10, Inc.’s unaudited Form 10-Q for the three months ended March 31, 2024, filed May 9, 2024. This differs from the request metadata naming Ridgepost Capital, Inc.; verify the intended issuer.

Business context

P10 is an alternative asset manager providing private-market solutions across private equity, venture capital, impact investing and private credit. It reports one operating segment. At quarter-end, fee-paying assets under management (FPAUM) were $23.846 billion, up 2.5% from year-end 2023; the company attributes growth mainly to capital raised and deployed, offset by fee step-downs and expirations.

Financial performance

MetricQ1 2024Q1 2023Change
Total revenue$66.1 million$57.3 million+15%
Management and advisory fees$65.1 million$56.6 million+15%
Operating income$12.1 million$4.9 million+148%
Net income$5.2 million$0.8 million+582%
Net income attributable to P10$5.0 million$0.6 millionUp $4.4 million
Diluted EPS$0.04$0.01Increased
Net cash from operating activities$11.0 million$20.8 millionDown 47%

Operating margin was approximately 18.3%, versus 8.5% a year earlier; net margin was approximately 7.9%, versus 1.3%. Revenue growth reflected organic FPAUM growth, particularly at Bonaccord and TrueBridge, and catch-up fees of $7.7 million versus $3.0 million. Management says average fee rates remained approximately 1%.

Company-presented non-GAAP measures: Adjusted EBITDA was $30.8 million versus $28.4 million; Fee-Related Earnings were $30.7 million versus $28.2 million; Adjusted Net Income was $25.4 million versus $25.5 million. These measures are not GAAP results.

Balance sheet, debt and liquidity

  • Cash, cash equivalents and restricted cash totaled $30.0 million at March 31, down $2.0 million from year-end. Operating cash flow was positive, but below the prior-year quarter.
  • Net debt obligations were $314.0 million, up $24.2 million from December 31, 2023. Principal comprised a $199.2 million term loan and $117.2 million drawn on a $125 million revolver. The company reported weighted-average SOFR rates of 7.39% on the term loan and 7.43% on the revolver; Q1 net interest expense was $5.8 million.
  • The credit agreement requires a maximum leverage ratio of 3.50; P10 reported compliance at quarter-end. It estimated that a 100-basis-point rate increase would add about $2.0 million of interest expense over the next 12 months.
  • The company’s debt maturity schedule lists $8.0 million due in 2024 and $308.5 million in 2025. The filing also states the credit facilities mature December 22, 2025; verify refinancing and repayment plans.
  • Due from related parties was $62.8 million, including a $52.7 million receivable tied to ECG’s Enhanced PC advisory agreement. Collection is expected as covered multi-year projects are completed and liquidated.
  • Total assets were $832.8 million, including $506.0 million of goodwill and $116.8 million of net intangible assets. Total equity was $400.1 million, down $25.1 million from year-end, principally amid share repurchases and dividends.

Material changes, outlook and notable items

  • Operating expenses rose 3% to $54.0 million. Compensation and benefits increased 4%, and general, administrative and other expenses rose 25%, partly offset by lower amortization and contingent consideration expense.
  • Management cited ongoing demand for private-market solutions, fundraising and FPAUM growth opportunities, and potential benefits to floating-rate private credit strategies from higher rates. It also flagged uncertain markets, fundraising cycles, competition for manager access, regulatory and compliance burdens, and the need for financing to support acquisitions and growth. No quantitative full-year guidance is provided.
  • Q1 financing included $47.5 million of debt borrowings and $23.7 million of repayments. P10 repurchased 3.68 million Class A shares for $30.0 million in March, and paid $3.8 million of dividends. The board authorized an additional $40 million repurchase capacity in February; $59.5 million had been spent under the program by quarter-end.
  • The board declared a $0.035-per-share quarterly dividend payable June 20, 2024, to holders of record May 31, 2024.
  • Potential WTI acquisition earnouts total up to $70 million, contingent on EBITDA hurdles and continued employment. The company considered only the first two hurdles probable at quarter-end; $29.2 million was accrued and no payments had been made. Separate ECG revenue-share arrangements had $16.2 million of accrued liabilities, with put options considered probable of exercise.
  • The company reported no material litigation losses expected beyond amounts already recognized, no material changes to previously disclosed risk factors, and effective disclosure controls. The COO’s planned May 2024 retirement carries $1.2 million of severance accrued in 2023. The CEO and CFO transition arrangements and associated compensation are also relevant context.

Key facts for investors to verify

  • Whether P10, Inc. is the intended issuer, given the Ridgepost Capital metadata mismatch.
  • FPAUM composition and sustainability of fee growth, including the $7.7 million of Q1 catch-up fees and the effect of future fund closings, fee step-downs and expirations.
  • Cash conversion: operating cash flow fell 47% year over year despite revenue and earnings growth; review working-capital movements and related-party receivable collection timing.
  • Debt refinancing, covenant headroom, and exposure to floating SOFR rates ahead of the stated 2025 facility maturity.
  • Expected timing and funding of WTI earnouts and ECG revenue-share put obligations, alongside ongoing buybacks and dividend payments.